INVOKANA
NDC 50090-5034, canagliflozin, tablet, film coated, from A-S Medication Solutions.
- Product NDC
- 50090-5034
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204042
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-5034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CANAGLIFLOZIN100 mg/1
Pharmacologic classes
P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-5034-0 | 50090503400 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5034-0) |
| 50090-5034-1 | 50090503401 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-5034-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8d5f892b-e4f3-4a9e-9a91-95e2fca34144
Use it
Look up 50090-5034 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-5034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-5034. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.